GSK To Launch Mepolizumab For Severe Asthma By Year-End
First interleukin-5 drug approved for adults with severe asthma that cannot be controlled by other treatments; sales force will only target specialists.
First interleukin-5 drug approved for adults with severe asthma that cannot be controlled by other treatments; sales force will only target specialists.